Search results
US drugs regulator gives LSD ‘breakthrough’ status for treating anxiety – why this is so significant...
EconoTimes· 6 days agoLSD was accidentally discovered by Albert Hofmann at the Sandoz pharmaceutical company in...
MindBio Therapeutics Scientists Present Landmark Women’s Health Trials. Company To Release Phase 2A...
Digital Journal· 42 minutes ago(CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio"), a clinical stage biopharma company pioneering microdosing treatments for mental health conditions showcases Dr Rachael ...
LSD Microdosing For PMS? After Confirming Antidepressant Effects, Clinical Trials Will Assess If It...
Benzinga· 2 days agoThe Australian-based biopharma company MindBio Therapeutics Corp. MBIO obtained regulatory approval...
Why Cannabis Stocks Popped Up to 80% on Tuesday
MSN News· 8 hours agoDespite short-term volatility, the long-term investment potential of pot stocks shines after the U.S. policy shift. The post Why Cannabis Stocks Popped...
Biden plans to drastically change federal rules on marijuana, here's where NC stands
Asheville Citizen-Times via Yahoo News· 14 hours agoAn anxiety disorder. An autism spectrum disorder. An autoimmune disorder. Anorexia nervosa. Cancer....
Veterans' groups eager to see cannabis reclassified, hope move expands care options
WJLA· 16 hours agoThe Drug Enforcement Administration will reportedly move to reclassify marijuana, or cannabis, as a...
This Small-Cap Stock Is Up 140% This Year and Here's Why It Can Go Even Higher
Motley Fool via Yahoo Finance· 7 days agoPromising results from a clinical trial have given investors reason for hope Investors have been...
The Top 3 Small-Cap Stocks to Buy in April 2024
InvestorPlace via Yahoo Finance· 7 days agoHigher interest rates, pricier debt and an overemphasis on mega-caps over the past year mean that top small-cap stocks have played second fiddle to...
DEA’s Psychedelic-Outlawing Effort Attacked by Private Industry | The Legal Intelligencer
Law.com· 3 days agoDespite the U.S. Food and Drug Administration’s approval of depression treatment drug Esketamine and...
Psychedelic Drug Market Poised to Hit $4.6B by 2030
High Times· 2 days agoA recent report shows a steady growth in the psychedelic drug market, however the report represents a much more conservative projection compared to past reports, which have blown that projection ...
